Several studies have demonstrated that NAMPT inhibition causes mitochondrial dysfunction in cancer cells in breast carcinoma, leukemia, pancreatic cancer and Burkitt’s lymphoma [62,68,69]. The gene discussed is NAMPT; the disease is pancreatic neoplasm.